Nicolet Advisory Services’s GSK GSK Stock Holding History

Nicolet Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.23M	Buy	24,429 +9,262	+61%	+$432K	0.08%	119
2025 Q3	$660K	Buy	15,167 +70	+0.5%	+$2.73K	0.05%	190
2025 Q2	$567K	Buy	15,097 +813	+6%	+$31.1K	0.05%	199
2025 Q1	$480K	Buy	14,284 +2,607	+22%	+$95.4K	0.05%	195
2024 Q4	$386K	Sell	11,677 -1,538	-12%	-$55.4K	0.04%	245
2024 Q3	$507K	Buy	13,215 +430	+3%	+$17.6K	0.05%	200
2024 Q2	$493K	Buy	12,785 +795	+7%	+$33.4K	0.05%	200
2024 Q1	$490K	Sell	11,990 -124	-1%	-$5.11K	0.05%	179
2023 Q4	$475K	Sell	12,114 -1,920	-14%	-$68.9K	0.05%	171
2023 Q3	$506K	Buy	14,034 +4,537	+48%	+$161K	0.06%	156
2023 Q2	$324K	Buy	9,497 +1,644	+21%	+$59K	0.04%	213
2023 Q1	$298K	Buy	+7,853	New	+$275K	0.03%	212

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nicolet Advisory Services's GSK Position: Q4 2025 in Review

Nicolet Advisory Services increased its GSK (GSK) stake by 61% in Q4 2025, buying an estimated $432K and bringing the position to 24,429 shares worth $1.23M. The position accounts for 0.08% of the portfolio, ranked #119.

Nicolet Advisory Services first reported a position in GSK in Q1 2023 and has held it in 12 quarters since. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Nicolet Advisory Services held 24,429 shares of GSK worth $1.23M as of Q4 2025.
Nicolet Advisory Services bought 9,262 GSK shares in Q4 2025, an estimated $432K.
GSK made up 0.08% of Nicolet Advisory Services's portfolio in Q4 2025, its #119 holding.
Nicolet Advisory Services first reported a position in GSK in Q1 2023 and has held it in 12 quarters since.
995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.